Life Science Investing Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Life Science Investing Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
Life Science Investing Journey Medical Corporation Reports Combined Emrosi Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
Life Science Investing Journey Medical Corporation to Participate in October 2025 Investor Conferences
Life Science Investing Journey Medical Corporation to Participate in September 2025 Investor Conferences
E-Power Resources Appoints New CEO and Expands Advisory Teams; Focus on Agressive Strategy for Tetepisca Graphite Project
Standard Uranium Receives Drill Permits and Initiates Ground Gravity Survey on the Corvo Uranium Project
